Neurogene Inc. Email Format
Biotechnology ResearchNew York, United States51-200 Employees
Neurogene Inc. is a biotechnology research company focused on developing genetic medicines for rare and devastating neurological diseases, with the aim of addressing the underlying causes of these disorders rather than just managing symptoms. Headquartered in New York City, it collaborates with experts worldwide to push forward a diverse pipeline of programs intended to help neurologically impaired and developmentally delayed children and their families. It operates in the biotechnology research sector and seeks to broaden access to genetic therapies for families affected by exceedingly rare conditions. In April 2026, Neurogene announced the appointment of Christy Shafer as chief commercial officer and named Christine Mikail to its board of directors.